Research update: New test for pulmonary fibrosis

A UT Health San Antonio lung specialist is the first in Texas to use a new genomic test to better and less invasively diagnose a patient with idiopathic pulmonary fibrosis (IPF), a serious chronic, progressive and scarring lung disease with an average survival time of less than five years after diagnosis.

Article Categories: News